Frontlight ResearchEarly access
Trial site
BIOMEDRO Biomedizinische Forschung und Entwicklung GmbH
- 2running trials
- 6closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Sjögren's disease3 trials
- Rheumatoid arthritis2 trials
- Ankylosing spondylitis1 trial
- Giant cell arteritis1 trial
- Osteoarthritis1 trial
- Polymyalgia rheumatica1 trial
- Phase
- Phase 34 trials
- Phase 22 trials
- Phase 42 trials
- Status
- Completed6 trials
- Active, not recruiting2 trials
- Lead sponsor
- Novartis Pharmaceuticals3 trials
- Amgen2 trials
- Eli Lilly and Company2 trials
- Horizon Therapeutics Ireland Designated Activity Company1 trial
Running trials
Closed trials
Completed
Completed
Completed
An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis
Completed
Completed
Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee Osteoarthritis
Completed
A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026